Biocept reverse split
WebSep 4, 2024 · September 4, 2024 - 4:28 pm. SAN DIEGO, Sept. 4, 2024-- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces that, as a result of the Company's one-for-ten reverse stock split which will … WebSep 4, 2024 · SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians …
Biocept reverse split
Did you know?
WebSep 4, 2024 · September 4, 2024 - 4:28 pm. SAN DIEGO, Sept. 4, 2024-- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to … WebSep 7, 2024 · The San Diego-based biotechnology company said the reverse stock split will increase the market price of its shares and help it regain compliance with Nasdaq's minimum bid price requirement. Shares of Biocept will start trading on the Nasdaq Capital Market on a post-split basis at market open Sept. 8 under the same ticker symbol, BIOC.
WebBiocept said in its Form 10K last month that it had applied for, and been granted, an additional 180 days to regain compliance. It will seek approval for a reverse stock split during the company's 2024 annual shareholder meeting, scheduled to … WebSep 4, 2024 · Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Biocept (NASDAQ:BIOC) -4.1% AH, will execute a 1:10 reverse split of its …
WebApr 4, 2024 · Stock Split History. Follow $0.33-0.0068 (-2.05%) 3:59 PM 04/06/23. ... See Biocept, Inc. (BIOC) history of stock splits. Includes date and ratio. Seeking Alpha - Go … WebSep 4, 2024 · Authorization for the reverse stock split was approved by the Company's stockholders at Biocept's 2024 Annual Meeting of Stockholders. The objective of the reverse stock split is to increase the market price for the Company's common stock to, among things, enable the Company to regain compliance with the $1.00 minimum bid …
WebMar 31, 2024 · The change in outstanding share count reflects the 1-for-10 reverse split of common stock effected in September 2024. Biocept reported cash and cash equivalents as of March 31, 2024 of $14.2 million, compared with $14.4 million as of December 31, 2024. Conference Call and Webcast
WebJul 16, 2024 · Biocept's board of directors has recommended a vote FOR the Proposal, which will authorize Biocept's board of directors to amend Biocept's Certificate of … fnf arch flpWebSep 8, 2024 · Authorization for the reverse split was approved by the company's stockholders at Biocept's 2024 annual shareholder meeting, although the vote was … fnf arch gamaverseWebSep 4, 2024 · SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- Biocept, Inc. (NASDAQ:BIOC), a leading commercial provider of molecular technologies designed to provide physicians … fnf arch chromatic scaleWebSep 4, 2024 · SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians … green to gold packet for nursing armyWebJul 16, 2024 · Biocept Inc: NASDAQ:BIOC: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.0075: 1.42%: 0.5375: 0.409: 0.70: 100: 09:01:40: Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Support Biocept Proposal to Authorize the … fnf arch dwpWebFor example, if a stockholder held only 15 shares of common stock immediately prior to the Reverse Stock Split and the Reverse Stock Split ratio selected by the Board was 1:25, … green to gold phase 2 deadlineWebMar 1, 2024 · About Biocept. Biocept is a molecular diagnostics company with commercialized assays for patients with carcinomas or melanomas. Our experts have spent years working to change the way physicians look at cerebrospinal fluid (CSF) in cancer patients. Biocept has developed a unique, patented methodology to isolate cancer … fnf arch hacker